Evofem Biosciences, Inc. financial data

Symbol
EVFM on OTC
Industry
Pharmaceutical Preparations
Location
12400 High Bluff Drive, Suite 600, San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Neothetics, Inc. (to 1/5/2018)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 12.1 % -40.3%
Quick Ratio 2.29 % -58.1%
Debt-to-equity -109 % +22.4%
Return On Equity -92 % +14.3%
Return On Assets 595 % +128%
Operating Margin -500 % +75.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 100M shares +4245%
Common Stock, Shares, Outstanding 82.8M shares +3181%
Entity Public Float 1.9M USD -97.9%
Common Stock, Value, Issued 8K USD
Weighted Average Number of Shares Outstanding, Basic 66.8M shares +4136%
Weighted Average Number of Shares Outstanding, Diluted 1.61B shares +102283%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 100M USD +1470%
Revenue from Contract with Customer, Excluding Assessed Tax 17.7M USD +19.5%
Research and Development Expense 2.86M USD -63.5%
Selling and Marketing Expense 10.2M USD -59.2%
General and Administrative Expense 11.5M USD -35.8%
Costs and Expenses 28.9M USD -48.9%
Operating Income (Loss) -11.2M USD +73.2%
Nonoperating Income (Expense) 71.6M USD -36%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 60.5M USD -14%
Income Tax Expense (Benefit) 8K USD +167%
Net Income (Loss) Attributable to Parent 60.4M USD -14%
Earnings Per Share, Basic 17.5 USD/shares -97.7%
Earnings Per Share, Diluted 7.17 USD/shares -98.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 639K USD -76.9%
Cash, Cash Equivalents, and Short-term Investments 2.8M USD -93.8%
Accounts Receivable, after Allowance for Credit Loss, Current 4.62M USD -11.2%
Inventory, Net 1.06M USD -71.1%
Assets, Current 7.21M USD -40%
Property, Plant and Equipment, Net 1.19M USD -28.8%
Operating Lease, Right-of-Use Asset 114K USD -96.5%
Other Assets, Noncurrent 36K USD -81.5%
Assets 8.55M USD -39.2%
Accounts Payable, Current 16M USD -6.52%
Employee-related Liabilities, Current 3.28M USD +112%
Accrued Liabilities, Current 4.75M USD +12.7%
Contract with Customer, Liability, Current 3.6M USD
Liabilities, Current 73.2M USD +4.97%
Operating Lease, Liability, Noncurrent 4M USD +52.3%
Other Liabilities, Noncurrent 0 USD
Liabilities 73.2M USD +4.93%
Accumulated Other Comprehensive Income (Loss), Net of Tax -781K USD -101%
Retained Earnings (Accumulated Deficit) -892M USD +6.04%
Stockholders' Equity Attributable to Parent -69.3M USD -24.5%
Liabilities and Equity 8.55M USD -39.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 123K USD
Net Cash Provided by (Used in) Financing Activities 1.7M USD -88.8%
Net Cash Provided by (Used in) Investing Activities -14K USD -367%
Common Stock, Shares Authorized 3B shares +500%
Common Stock, Shares, Issued 82.8M shares +3181%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 109K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 692K USD +8.81%
Deferred Tax Assets, Valuation Allowance 145M USD +2%
Deferred Tax Assets, Gross 145M USD +1.32%
Operating Lease, Liability 114K USD -41.5%
Depreciation 12K USD -95.1%
Payments to Acquire Property, Plant, and Equipment 14K USD +367%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.7M USD -110%
Lessee, Operating Lease, Liability, to be Paid 121K USD -42.9%
Property, Plant and Equipment, Gross 1.88M USD -34.5%
Operating Lease, Liability, Current 113K USD -34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 55K USD +511%
Lessee, Operating Lease, Liability, to be Paid, Year One 66K USD -39.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7K USD -58.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5K USD -99.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.05M USD +2.11%
Operating Lease, Payments 64K USD -89.5%
Additional Paid in Capital 824M USD +0.38%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 960K USD -48.1%
Interest Expense 564K USD -0.18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%